Navigation Links
China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
Date:6/1/2011

ekly statistical release of the Federal Reserve Board, as of Thursday, March 31, 2011. No representation is made that the RMB amounts could have been or could be converted into U.S. dollars at that rate or at any other rate on March 31, 2011 or at any other dates.

Product Development PlanThe Company plans to focus on the following product development activities with respect to its molecular diagnostic products:

FISH

  • to develop more applications in the areas of prenatal diagnosis, cancer detection and companion diagnostics for cancer targeted drugs through internal research and development.

  • SPR

  • to develop a new automated analyzer for hospitals and independent laboratories to conduct HPV tests using our DNA chips through internal research and development.

  • PCR

  • to develop more assays in the area of companion diagnostics for cancer targeted drugs through internal research and development.

  • Update on Receivable from ChengxuanAs of March 31, 2011, the remaining amount of the receivable from Chengxuan, a company which is one of the Company's major shareholders and is owned by Mr. Xiaodong Wu, was reduced from US$18 million to US$15 million. This receivable relates to the sale of the Company's HIFU business to Chengxuan. Subsequently, Chengxuan paid US$8 million to the Company and indicated that the remaining balance of US$7 million together with interest thereon will be paid in full before June 30, 2011.

    Non-GAAP Measure DisclosuresThe Company reported its operating results in accordance with U.S. generally accepted accounting principles ("GAAP") for the three months and the year ended March 31, 2010 and 2011, respectively. The Company also presented non-GAAP information, which included EBITDA and adjusted EBITDA, for the three months and the year ended March 31, 2010 and 2011, respectively. The non-GAAP measures are defined below:

  • Non-GAAP gross profit represents gross p
    '/>"/>

  • SOURCE China Medical Technologies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

    Related medicine technology :

    1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
    2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
    3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
    4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
    5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
    6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
    7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
    8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
    9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
    10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
    11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "MEMS Gyroscopes ... Costing Analysis" report to their offering. ... MEMS gyroscopes for tactical grade applications made a ... in term of reliability. They are now accepted ...
    (Date:12/15/2014)... HERZLIYA PITUACH, Israel , Dec. 15, 2014 ... IMNP ) announced today that its Board of Directors has ... Daniel Teper who continues as Chief Executive Officer ... Board of Directors since 2013. Immune,s new Chairman, ... represent the interest of shareholders and to continue to support ...
    (Date:12/15/2014)... Dec. 15, 2014 As medical device manufacturers ... Labeling) markup language standard, content teams have a greater ... to work with the standard. Starting January 2015, Data ... webinars on the benefits and the critical aspects of ... be facilitated by Howard Shatz , DCL,s SPL ...
    Breaking Medicine Technology:MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3
    (Date:12/15/2014)... December 15, 2014 South Florida’s leading urgent ... holidays can be a daze of hassle, hustle, and bustle ... while decking halls, to burns when making special meals and ... that can happen at any time. To prevent this season ... has made a list of helpful and healthful holiday tips ...
    (Date:12/15/2014)... Health Dialog, a leading provider of ... has received Patient Oriented Accreditation from the National ... Management (DM) Programs for asthma, congestive heart failure, ... and diabetes. This marks the 12th continuous year ... Management (DM) Programs, reaffirming Health Dialog’s focus and ...
    (Date:12/15/2014)... The increase in prevalence of disabling hearing ... factors which is contributing to the growth in the global ... treatment of hearing loss and balance disorders are known as ... microphone, speaker and amplifier. The global market is expected to ... the period from 2014 to 2019. Some of the factors ...
    (Date:12/15/2014)... (PRWEB) December 15, 2014 In ... to bring attention to restrictive state laws that ... paper on this important area of public health ... Can Compromise the Integrity of Independent Review, contends ... access of independent peer review determinations can result ...
    (Date:12/15/2014)... Kenmode Precision Metal Stamping has announced that ... Quality Assurance. He brings more than 15 years ... for manufacturers in the U.S. and abroad. , ... at Sonoco Products Company in the Protective Solutions Division, ... Assurance Manager for Prince Industries, all in the Chicago ...
    Breaking Medicine News(10 mins):Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2
    ... The sanofi-aventis U.S. Community Health Partnership - It,s ... Help Improve Patient Care by Connecting Patients and ... CommunitiesBRIDGEWATER, N.J., Feb. 5 Sanofi-aventis announced the ... It,s In Our Hands , in the Bronx ...
    ... facility expected to open in 2011 and bring ... 5 CVS/pharmacy, America,s largest retail pharmacy, announced ... a 750,000 square foot distribution center in Chemung ... subject to final negotiations and approvals from state ...
    ... marketing website recently debuted to help service providers and medical practices ... giving medical practices the edge needed to build their businesses. ... ... service providers and physicians in search of a customized ...
    ... China, Feb. 5 /PRNewswire-Asia-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC ... manufacturer and distributor of high-quality, pharmaceutical grade,glucose products ... State,Council approved plan to spend a total of ... provide universal primary medical services. Over the next ...
    ... Tibotec, Inc. today announced it has submitted ... Administration (FDA) seeking traditional approval for INTELENCE(TM) (etravirine) ... The application for traditional approval includes 48-week data ... and DUET-2. INTELENCE is currently marketed in ...
    ... Technologies, Inc. (Nasdaq: PMTI ), a leading ... today announced financial results for the fourth quarter and ... quarter ended December 31, 2008 were $17.2 million, of ... royalty revenues, $0.5 million were funded development revenues, and ...
    Cached Medicine News:Health News:Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care 2Health News:Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care 3Health News:CVS/pharmacy Announces Plans for New Distribution Center in Southern New York 2Health News:Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines 2Health News:Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines 3Health News:Shengtai Pharmaceutical, Inc. Comments on China's Recently Approved Health Care Reform Plan 2Health News:Shengtai Pharmaceutical, Inc. Comments on China's Recently Approved Health Care Reform Plan 3Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 2Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 3Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 4Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 3Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 4Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 6Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 8Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 9Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 10
    ... a medical device designed to handle the ... and archiving demands of the EEG laboratory. ... that helps organize workflow and the collection, ... database and powerful search capability keeps track ...
    ... The P3000 heralds a new concept in pupillometry, ... infrared optical system developed for the P2000. ... in which we have paid particular attention to ... Our new system is extremely flexible, allowing you ...
    ...
    ... Peg electrodes typically are ... to enable epidural recording of ... contacts and are furnished in ... skull thicknesses. A 4.6 mm ...
    Medicine Products: